Rep. Celeste Maloy

Maddy summaryThe America's Wildlife Habitat Conservation Act creates new funding mechanisms to support wildlife habitat conservation across the United States. It establishes a $300 million annual subaccount for states, territories, and the District of Columbia to restore habitat for species listed as threatened or endangered under federal or state law, and to prevent species from needing such listings, with at least 15% of funds dedicated to endangered species recovery. The bill also creates a $20 million annual account specifically for tribal wildlife conservation programs. Funds must be used for habitat restoration, species conservation, invasive species management, and must be tracked through annual reporting requirements to demonstrate effectiveness.

Maddy summaryHR 3396, the Fire Department Repayment Act of 2023, requires the Secretaries of Agriculture, Interior, Homeland Security, and Defense to establish standard procedures for federal fire suppression cost share agreements within one year. It mandates reviewing existing agreements to align them with local cooperative fire protection agreements and conducting second-level reviews after wildfires, involving state and local fire organizations. The bill directly affects fire departments and agencies participating in these cost-sharing arrangements under the Reciprocal Fire Protection Act. Key changes include standardized procedures for agreement management and post-wildfire reviews to ensure cost-sharing compliance.

Maddy summaryHR 3269, the Law Enforcement Innovate to De-Escalate Act, exempts specific less-than-lethal projectile devices from federal firearm taxes and National Firearms Act restrictions. The bill defines these devices as those firing projectiles at under 500 feet per second and designed not to cause death or serious injury. This directly affects law enforcement agencies using such devices and manufacturers producing them, by removing tax burdens and registration requirements. The key change is creating a clear legal exemption for these devices under federal law, streamlining their use for de-escalation purposes.

Maddy summaryHR 3049 ratifies a land exchange agreement between Utah's School and Institutional Trust Lands Administration, the state of Utah, and the federal government (via the Secretary of the Interior). The bill authorizes swapping specific federal lands for equivalent state lands managed by the Administration, requiring the exchange to be completed within 45 days of enactment. Key provisions include equalizing land values through a federal appraisal process (based on 2023 values) and resolving discrepancies within 90 days, while excluding certain parcels in Sunnyside, Utah, from the exchange as specified in the agreement. This directly affects Utah's school trust lands system and federal land management in the state.

Maddy summaryHR 10050 requires the Health and Human Services Secretary to study pharmacy benefit manager (PBM) audit practices within one year of enactment. The study will assess financial impacts on independent pharmacies, evaluate if audit deadlines align with medication shelf lives (including FDA-approved 2+ year shelf lives), and examine audit transparency. It will also identify fairer audit processes to reduce burdens on pharmacists while maintaining audit integrity. The report must cover audits for Medicare, Medicaid, and insurance plans, including recommendations for transparency improvements.

Maddy summaryThe Pharmacists Fight Back Act (HR 9096) sets new rules for Pharmacy Benefits Managers (PBMs) working with federal health care programs like Medicare Part D and Medicaid. It requires PBMs to reimburse in-network pharmacies at a rate covering the drug's actual cost plus a small fee (capped at $25), and to reduce patient cost-sharing by at least 80% of rebates received from drug manufacturers. The bill bans PBMs from steering patients to specific pharmacies, charging patients more than pharmacies are paid, or using rebates to lower pharmacy payments after claims are processed. It also mandates public reporting of drug pricing data to improve transparency, ensuring patients and pharmacies receive fairer treatment under federal health programs.

Maddy summaryThe PROVE IT Act of 2024 directs the U.S. Energy Secretary to study and publicly report on the greenhouse gas emissions intensity of key U.S. manufactured products (like steel, aluminum, lithium batteries, and critical minerals) compared to those produced in "covered countries" (including the EU, China, and major trading partners). It requires a transparent methodology for calculating emissions data, identifies gaps in existing data, and establishes a public online database showing U.S. emissions advantages for these products. The bill also mandates an annual report on foreign countries using forced labor or human rights abuses in the production of critical minerals or rare earths. Importantly, it clarifies the study does not create new taxes, fees, or mandatory reporting requirements.

Maddy summaryThis bill expands Medicare coverage to include home infusion treatment for people with Alpha-1 Antitrypsin Deficiency Disorder, a genetic condition causing lung and liver damage. It specifically covers "augmentation therapy" (a standard treatment using Alpha-1 Proteinase Inhibitor) when administered in a patient's home by qualified providers. Medicare will pay 80% of the cost for intravenous kits and up to 2 hours of nursing care during these home infusions, starting January 1, 2025. The change directly affects Medicare beneficiaries with this condition who require home-based treatment and their qualified home infusion providers.

Maddy summaryThis bill expands Medicare Part B coverage to include specific pharmacist services, directly affecting Medicare beneficiaries and pharmacists who provide these services. It adds new coverage for pharmacist evaluations and treatments related to certain illnesses (like COVID-19, flu, or strep throat) and public health emergencies, requiring payment at 80% of the lesser of actual charge or 85% of physician payment rates (100% during emergencies). The bill also prohibits balance billing for these services, ensuring beneficiaries pay only the standard Medicare copayment. These changes aim to improve access to pharmacist care during health crises while aligning payment with existing physician service frameworks.

Maddy summaryHR 1666 extends deadlines for ambulance service reimbursement rules under Medicare. It amends Section 1834(l) of the Social Security Act by changing dates from 2025 to 2028 in two specific provisions: paragraph (12)(A) and paragraph (13)(A). This delay gives ambulance providers additional time to adjust to existing Medicare payment rules. The bill directly affects Medicare-certified ambulance services and the patients relying on ground ambulance care covered by Medicare.